Literature DB >> 35032307

Neural Stem Cells Therapy for Ischemic Stroke: Progress and Challenges.

Tong Zhao1, Tongming Zhu2, Liqian Xie2, Yao Li3, Rong Xie2, Feng Xu4, Hailiang Tang5, Jianhong Zhu6.   

Abstract

Ischemic stroke, with its high morbidity and mortality, is the most common cerebrovascular accident and results in severe neurological deficits. Despite advances in medical and surgical intervention, post-stroke therapies remain scarce, which seriously affects the quality of life of patients. Over the past decades, stem cell transplantation has been recognized as very promising therapy for neurological diseases. Neural stem cell (NSC) transplantation is the optimal choice for ischemic stroke as NSCs inherently reside in the brain and can potentially differentiate into a variety of cell types within the central nervous system. Recent research has demonstrated that NSC transplantation can facilitate neural recovery after ischemic stroke, but the mechanisms still remain unclear, and basic/clinical studies of NSC transplantation for ischemic stroke have not yet been thoroughly elucidated. We thus, in this review, provide a futher understanding of the therapeutic role of NSCs for ischemic stroke, and evaluate their prospects for future application in clinical patients of ischemic stroke.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ischemic stroke; Neural stem cells; Transplantation

Mesh:

Year:  2022        PMID: 35032307     DOI: 10.1007/s12975-022-00984-y

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.800


  89 in total

1.  Tracking neural stem cells in patients with brain trauma.

Authors:  Jianhong Zhu; Liangfu Zhou; FengGe XingWu
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

2.  Tracking induced pluripotent stem cells-derived neural stem cells in the central nervous system of rats and monkeys.

Authors:  Hailiang Tang; Hongying Sha; Huaping Sun; Xing Wu; Liqian Xie; Pu Wang; Chengshi Xu; Christian Larsen; Helen L Zhang; Ye Gong; Ying Mao; Xiancheng Chen; Liangfu Zhou; Xiaoyuan Feng; Jianhong Zhu
Journal:  Cell Reprogram       Date:  2013-09-10       Impact factor: 1.987

Review 3.  Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior.

Authors:  J Tiago Gonçalves; Simon T Schafer; Fred H Gage
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 4.  Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation.

Authors:  J Zhu; X Wu; H L Zhang
Journal:  Curr Drug Targets       Date:  2005-02       Impact factor: 3.465

Review 5.  Advances in Stroke: Therapies Targeting Stroke Recovery.

Authors:  Lorie G Richards; Steven C Cramer
Journal:  Stroke       Date:  2020-12-22       Impact factor: 7.914

6.  MRI Tracking of iPS Cells-Induced Neural Stem Cells in Traumatic Brain Injury Rats.

Authors:  Lili Jiang; Ronggang Li; Hailiang Tang; Junjie Zhong; Huaping Sun; Weijun Tang; Huijuan Wang; Jianhong Zhu
Journal:  Cell Transplant       Date:  2018-12-21       Impact factor: 4.064

7.  Perfusion Defects and Collateral Flow Patterns in Acute Small Subcortical Infarction: a 4D Dynamic MRI Study.

Authors:  Yen-Chu Huang; Jiann-Der Lee; Yi-Ting Pan; Hsu-Huei Weng; Jen-Tsung Yang; Leng-Chieh Lin; Yuan-Hsiung Tsai
Journal:  Transl Stroke Res       Date:  2021-10-14       Impact factor: 6.800

View more
  2 in total

1.  Editorial: Mitochondrial Dysfunction in Stroke.

Authors:  Feng Yan; Hailiang Tang; Lin Wang; Lei Huang; John Zhang
Journal:  Front Aging Neurosci       Date:  2022-03-29       Impact factor: 5.750

2.  N-acylethanolamide metabolizing enzymes are upregulated in human neural progenitor-derived neurons exposed to sub-lethal oxidative stress.

Authors:  R Scott Duncan; Sean M Riordan; Conner W Hall; Andrew J Payne; Kent D Chapman; Peter Koulen
Journal:  Front Cell Neurosci       Date:  2022-08-08       Impact factor: 6.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.